GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UnicoCell Biomed Co Ltd (TPE:6794) » Definitions » Scaled Net Operating Assets

UnicoCell Biomed Co (TPE:6794) Scaled Net Operating Assets : 0.25 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is UnicoCell Biomed Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

UnicoCell Biomed Co's operating assets for the quarter that ended in Dec. 2024 was NT$224.37 Mil. UnicoCell Biomed Co's operating liabilities for the quarter that ended in Dec. 2024 was NT$25.05 Mil. UnicoCell Biomed Co's Total Assets for the quarter that ended in Sep. 2024 was NT$796.49 Mil. Therefore, UnicoCell Biomed Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.25.


UnicoCell Biomed Co Scaled Net Operating Assets Historical Data

The historical data trend for UnicoCell Biomed Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UnicoCell Biomed Co Scaled Net Operating Assets Chart

UnicoCell Biomed Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.41 0.37 0.63 0.47 0.29

UnicoCell Biomed Co Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.27 0.26 0.21 0.25

Competitive Comparison of UnicoCell Biomed Co's Scaled Net Operating Assets

For the Biotechnology subindustry, UnicoCell Biomed Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UnicoCell Biomed Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, UnicoCell Biomed Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where UnicoCell Biomed Co's Scaled Net Operating Assets falls into.



UnicoCell Biomed Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

UnicoCell Biomed Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(224.369-25.045)/685.929
=0.29

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=777.889 - 553.52
=224.369

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=93.281 - 62.017 - 6.219
=25.045

UnicoCell Biomed Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(224.369-25.045)/796.494
=0.25

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=777.889 - 553.52
=224.369

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=93.281 - 62.017 - 6.219
=25.045

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


UnicoCell Biomed Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of UnicoCell Biomed Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


UnicoCell Biomed Co Business Description

Traded in Other Exchanges
N/A
Address
Minquan East Road, 5th Floor, No. 13-20, Section 6, Neihu District, Taipei, TWN, 11494
UnicoCell Biomed Co Ltd is a biotechnology company. Its main business includes new drug R&D and human tissue-derived stem cell inspection and testing, extraction, storage, and technology R&D.

UnicoCell Biomed Co Headlines

No Headlines